Navigation Links
BHR Pharma Investigational Traumatic Brain Injury Treatment Receives European Medicines Agency Orphan Medicinal Product Designation
Date:2/13/2013

HERNDON, Va., Feb. 13, 2013 /PRNewswire/ -- BHR Pharma, LLC announced today the European Medicines Agency (EMA), responsible for evaluating medicines developed for use in the European Union, granted an orphan medicinal product designation for treating moderate and severe traumatic brain injury (TBI) to its proprietary intravenous progesterone infusion agent, BHR-100.  The agent currently is being evaluated as a neuroprotective treatment for severe traumatic brain injury (TBI) in the global, Phase III SyNAPSe® clinical trial.

BHR Pharma is sponsoring SyNAPSe with the intent to bring the first-ever approved TBI treatment to market.  The trial currently has 154 participating sites, including U.S. Level 1 and 2 trauma centers, in 21 countries on four continents. 

"Traumatic brain injury or TBI is a global problem that needs a global solution, and with providing an orphan drug designation for BHR-100 in Europe, the EMA acknowledges the importance of supporting the development of this potential treatment in TBI," said Roland Gerritsen van der Hoop , BHR Pharma Chief Medical Officer and Head of Global R&D. "BHR is committed to bringing this first-of-its-kind treatment to market with the hope of demonstrating progress in a condition with no approved therapies."

To qualify for orphan designation in Europe, a medicine must meet the following criteria:

  • The new medicine must be intended for the treatment, prevention or diagnosis of a disease that is life threatening or chronically debilitating;
  • The prevalence of the disease in the EU most not be more than five of every 10,000 people;
  • The new medicine must be of significant potential benefit to those affected by the disease.

In 2009, the U.S. Food and Drug
'/>"/>

SOURCE BHR Pharma, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... LA JOLLA, Calif. , June 1, 2015 ... RGLS ), a biopharmaceutical company leading the discovery ... today that Kleanthis G. Xanthopoulos , Ph.D. ... and as a member of Regulus, Board of ... the biotechnology industry.  Paul Grint, M.D., who previously ...
(Date:6/1/2015)... 1, 2015  bioMérieux, a world leader in the ... invited to join the White House Forum on Antibiotic ... U.S. as a means to address antibiotic resistance. Over ... June 2, 2015, to discuss the possible ways to ... the emergence of antibiotic-resistant bacteria, and prevent the spread ...
(Date:6/1/2015)... Pa. , June 1, 2015 Select ... that MJ Acquisition Corporation, a joint venture that Select ... XII, L.P., has completed its previously announced acquisition of ... the new joint venture. About Select ... operator of specialty hospitals and outpatient rehabilitation clinics in ...
Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 2Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 3
... Oct. 7 Sunridge International (OTC Bulletin Board: ... Trabeculoplasty (PNT) non-invasive treatment for glaucoma and ocular hypertension, ... by Beijing Vision World Trading Co. Ltd. (BVW), in ... patient research studies before gaining regulatory approval by China,s ...
... Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ... evaluating the use of Nexavar® (sorafenib) tablets will be presented ... October 8-12, 2010 in Milan, Italy. "It,s ... its first indication, advanced kidney cancer, and since that time ...
Cached Medicine Technology:Sunridge Advances its PNT Glaucoma Treatment Throughout China 2Bayer and Onyx Announce Nexavar Data Presentations at 35th European Society for Medical Oncology Congress 2Bayer and Onyx Announce Nexavar Data Presentations at 35th European Society for Medical Oncology Congress 3Bayer and Onyx Announce Nexavar Data Presentations at 35th European Society for Medical Oncology Congress 4
(Date:6/1/2015)... 2015 Sharenote, a leading web-base electronic ... Healthcare Industry this week in Louisiana. The entrepreneurial trio ... days to provide potential providers with the tools and ... monitor risk within their network. , Find out ... being used by more than 250 practices. , ...
(Date:6/1/2015)... Orlando, Florida (PRWEB) June 01, 2015 ... have generously donated $88,000 of the best superfood ... of the record-breaking floods in Texas. , "Monica ... Adams and Natural News in distributing Living Fuel Super ... victims of the millennial floods in Texas," KC Craichy ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 More than 22 ... summer months when school is out and they lose access ... Month and America’s dairy farmers and milk companies are on ... need with The Great American Milk Drive. , In ... provided in the school cafeteria for the bulk of their ...
(Date:6/1/2015)... Northridge dentist , Dr. Michel Elyson, ... promotion on Invisalign for a limited time only. With ... to $3,700. Patients can find out about their candidacy ... the extent of correction they need. This promotion expires ... any other offer. , Invisalign has continued to ...
(Date:6/1/2015)... 01, 2015 Listen to Volvo’s Director ... companies are using more granular data to create better ... new industry voices in Josep Celaya Gonzalez, CIO at ... ParkTAG. As an automotive insurer, MAPFRE are well versed ... easy-to-use solution to the driver. Award winning start-up ParkTAG ...
Breaking Medicine News(10 mins):Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 2Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 3Health News:Summer Nutrition Vital for Kids who Depend on Schools for Healthy Foods 2Health News:Northridge Dentists, Drs. Michel Elyson and Ramin Assili, are Now Offering a Limited Time Promotion on Invisalign 2Health News:Complimentary Webinar: Volvo, MAPFRE and Award Winning Start-Up discuss new Frontier of In-Car Services 2
... in a New Law and Manages Applicants, PaperworkMADRID, April 1 ... IBM ), today announced that Junta de Castilla ... in Spain, will be helping its citizens gain quicker access to ... a new system built around IBM ILOG JRules. The new system ...
... 2009) It appears that a drug commonly used ... on the compulsive behavior of kleptomaniacs it curbs their ... of Minnesota., The Medical School,s Department of Psychiatry conducted an ... who spent an average of at least one hour a ...
... Uneasiness and Limited Resources Create Missed Opportunities for Smokers ... (HCPs) are one of the most important allies a ... health risks of smoking and learning about the quitting ... smokers (21%) never talked to a HCP ...
... first-ever genetic link to the reason African-Americans are at increased ... researchers at the University of Alabama at Birmingham (UAB) is ... testing. In the study, African-Americans with a Pro72 protein variant ... advanced form of colon cancer compared to whites, the researchers ...
... HARBIN, China, March 31 /PRNewswire-Asia-FirstCall/ -- China Sky ... Company") (Nasdaq: CSKI ), a,leading fully ... Republic of China ("PRC"), today announced that it ... Exchange Commission,for its Annual Report on Form 10-K. ...
... providing patients with safe, reliable care using affordable medical equipment from ... ... with an unrelenting economic outlook, many surgery centers and hospitals are ... from DRE, a medical and surgical equipment supplier recently named ...
Cached Medicine News:Health News:Spain's Junta De Castilla y Leon Streamlines Benefits Delivery for Dependent Care With IBM ILOG JRules 2Health News:Not Enough Smokers Find Quit Support at the Doctor's Office 2Health News:Not Enough Smokers Find Quit Support at the Doctor's Office 3Health News:Not Enough Smokers Find Quit Support at the Doctor's Office 4Health News:China Sky One Medical, Inc. Files for Extension to File Form 10-K 2Health News:Healthcare Facilities Focusing on Affordability, Dependability 2Health News:Healthcare Facilities Focusing on Affordability, Dependability 3
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Inquire...
BD Vacutainer® Heparin Tubes are spray-coated with either lithium heparin or sodium heparin and are used for plasma determinations in chemistry....
ESR-Vacuum Tubes are evacuated tubes used for the collection of venous blood. ESR-Vacuum Tubes are used to transport and process blood for testing the Erythrocyte Sedimentation Rate (ESR) of whole bl...
Medicine Products: